- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-000345-70.
Displaying page 1 of 1.
EudraCT Number: 2014-000345-70 | Sponsor Protocol Number: M12-914 | Start Date*: 2014-07-01 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Veliparib (ABT-888) in Her-2 Negative Metastatic or Locally Advanced Unresectable B... | |||||||||||||
Medical condition: HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated mutation (BRCA1 and BRCA2) Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) AT (Completed) SE (Prematurely Ended) GB (GB - no longer in EU/EEA) DK (Completed) PT (Completed) DE (Prematurely Ended) BE (Prematurely Ended) CZ (Completed) NO (Completed) HU (Prematurely Ended) IT (Prematurely Ended) NL (Completed) LV (Completed) ES (Prematurely Ended) FR (Prematurely Ended) LT (Completed) EE (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
